Juvenile Idiopathic Arthritis

Advertisement
Mithu Maheswaranathan, MDRheumatology | October 11, 2023
Dr. Mara Becker spoke on the management of adults with JIA including uveitis and macrophage activation syndrome.
Kaitlyn D’OnofrioRheumatology | September 12, 2023
Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read an ...
Kaitlyn D’OnofrioRheumatology | September 12, 2023
A study analyzed the prevalence of opportunistic infections in patients with juvenile idiopathic arthritis (JIA). ...
Kaitlyn D’OnofrioRheumatology | February 7, 2020
Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read about the ...
Kaitlyn D’OnofrioRheumatology | September 12, 2023
A recent study concluded that “timing matters” and that early, aggressive treatment trumps delayed, conservative ...
Kaitlyn D’OnofrioOncology | September 12, 2023
A newly published study examined trends in the risk of cancer among patients with juvenile idiopathic arthritis (JIA). ...
Kaitlyn D’OnofrioRheumatology | September 12, 2023
A new study testing the safety and efficacy of adalimumab for polyarticular‐course juvenile idiopathic arthritis found ...
Kaitlyn D’OnofrioRheumatology | July 12, 2019
Here are the top stories covered by DocWire News this week in the Rheumatology section. In this edition, read about the ...
Kaitlyn D’OnofrioRheumatology | September 12, 2023
A new study found a significant association between exposure to metals—found in fish—and juvenile idiopathic ...
Kaitlyn D’OnofrioRheumatology | September 11, 2023
The Food and Drug Administration (FDA) approved a second biosimilar for etanercept (ENBREL, Amgen). ...
Kaitlyn D’OnofrioRheumatology | April 25, 2023
A recent study published in Arthritis & Rheumatology found that pregnant women with rheumatoid arthritis (RA) or ...
Advertisement